Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
To help clinicians make best use of genome and exome sequencing, a new report offers a primer that distils the technology of the Human Genome Project down to practical tools.
Scientists are mystified by the mechanism that 'reactivates' dormant viruses such as herpes. Now, a new study suggests interactions with other infections may be responsible.
A 5-year study of capuchin monkeys suggests foraging for hard-to-find insects may have helped our early ancestors' brains evolve the thinking ability that led to advanced tool use.